As technology races ahead, we appreciated the expertise of @ValsamoA from @hopkinskimmel as she presented her thoughts on the clinical value of liquid biopsy and #MRD detection at #AACR26. With a special call-out for ctDNA-adaptive clinical trials. https://t.co/5BW4hO689s